<DOC>
	<DOCNO>NCT02176395</DOCNO>
	<brief_summary>The purpose study explore pharmacological mechanism Danhong injection treatment acute ischemic stroke .</brief_summary>
	<brief_title>Multi- '' Omics '' Research Danhong Injection Treat Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>1 . Female male inpatient Age : 18 70 year . Clinical diagnosis ischemic stroke cause measurable neurological deficit define impairment language , motor function , cognition and/or gaze , vision neglect . Ischemic stroke defined event characterize sudden onset acute focal neurologic deficit presume due cerebral ischemia CT scan excludes hemorrhage . Clinical diagnosis `` Xueyu Zheng '' ( Blood Stasis Syndrome ) score Chinese medicine symptom scale `` Xueyu Zheng '' ischemic stroke ≥ 20 . The Chinese medicine symptom scale `` Xueyu Zheng '' define follow ( 1 ) hemiplegia10 , ( 2 ) numbness limbs10， ( 3 ) dark face9 , ( 4 ) purple dark lip8 , ( 5 ) Roughness skin4 , ( 6 ) pain fixed point5 , ( 7 ) purple dark tongue10 , ( 8 ) ecchymosis tongue10 , ( 9 ) purple sublingual vessel10 , ( 10 ) varicose sublingual vessel8 , ( 11 ) unsmooth pulse8 , ( 12 ) intermittent pulse1 . Onset symptoms 1 week prior initiation administration study drug . Clinical diagnosis cerebral anterior circulation obstruction . 4≤NIHSS＜20 . Patient willing participate voluntarily sign write patient inform consent . Informed consent obtain patient subject 's legally authorize representative relative , defer applicable , accord regulatory legal requirement participate center . 2 . Female male healthy volunteer Age : 18 70 year . Medical history , physical examination , vital sign , electrocardiogram ( ECG ) laboratory result ( include renal function , hepatic function , et al ) clinically significant finding . Healthy volunteer willing participate voluntarily sign write informed consent form . Informed consent obtain volunteer , accord regulatory legal requirement participate center . 1 . Female male inpatient Evidence intracranial hemorrhage ( ICH ) cerebral disease ( eg.vascular malformation , tumor , abscess multiple sclerosis etc . ) CTor MRIscan . Patients thrombolysis endovascular treatment . Known history allergy suspect allergic drug . Blood glucose 2.8 &gt; 16.8 mmol / l treatment diabetes severe complication due diabetes ( eg . peripheral neuropathy , diabetic gangrene ) . Liver function impairment value ALT AST 1.5fold normal value . Renal dysfunction value serum creatinine 1.5fold normal value . Severe cardiac dysfunction echocardiogram grade heart function Ⅲ grade . History prior stroke mRS ≥2 . Complicated atrial fibrillation . Severe stroke assessed appropriate imaging technique ( eg . massive cerebral infarction include one lobe brain 1/3 bloodsupply area middle cerebral artery ) . Prior disable patient . Hemorrhagic tendency recent severe dangerous bleed 3 month . Suspected addicted alcohol drug abuse . With severe complication would make condition complicate assessed investigator . Woman pregnancy , lactation positive result pregnancy test , woman want pregnant recent 6 month . Woman menstrual period . Patient participate trial participate trial recent 3 month . 2 . Healthy volunteer Had know history chronic disease include stroke , heart disease , diabetes , COPD , Neuropsychiatric diseases chronic infectious disease , etc . Coagulation disorder . Conditions increase bleed risk . Trauma surgery 6 month prior study . Use medication 4 week prior trial . History drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Acute Ischemic Stroke</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Traditional Chinese Medicine</keyword>
	<keyword>Proteomics</keyword>
</DOC>